MCJCF yields 40.00% · PFE yields 6.13%● Live data
📍 MCJCF pulled ahead of the other in Year 1
Combined, MCJCF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of MCJCF + PFE for your $10,000?
Majestic Corporation Plc engages in the recycling of catalytic converters, telecom equipment, and printed circuit boards scrap. It recycles precious and non-ferrous metals from obsolete mechanical and industrial materials, including legacy electrical and electronic equipment, precious metals sludge, copper/precious metals residues, electric motors, starters and alternators, shredded motors, wire/cables, aluminum, copper/brass, transformers, and shredded metals. It provides services, such as collection, processing, and the selling of the metals back to the refineries so they can produce the metals back to the supply chain. The company's segment includes solar industries, battery materials, printed circuit boards, platinum group metals refinery, and Non-Ferrous metals recovery. The company also provides recycling services and asset management consultancy to the telecommunications and recycling industries. The company operates in the United States, Malaysia, Italy, Mexico, Australia, the United Kingdom, Hong Kong, and internationally. The company was incorporated in 2021 and is based in Deeside, United Kingdom.
Full MCJCF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.